Skip to main content
Top
Published in: Archives of Dermatological Research 4/2019

Open Access 01-05-2019 | Systemic Sclerosis | Review

The role of adipokines in systemic sclerosis: a missing link?

Authors: Jakub Żółkiewicz, Anna Stochmal, Lidia Rudnicka

Published in: Archives of Dermatological Research | Issue 4/2019

Login to get access

Abstract

Systemic sclerosis is a multiorgan autoimmune disease characterized by vasculopathy and tissue fibrosis of unknown etiology. Recently, adipokines (cell signaling proteins secreted by adipose tissue) have attracted much attention as a cytokine family contributing to the various pathological processes of systemic sclerosis. Adipokines, such as leptin, adiponectin, resistin, adipsin, visfatin or chemerin are a heterogenic group of molecules. Adiponectin exhibits anti-fibrotic features and affects inflammatory reactions. Leptin promotes fibrosis and inflammation. Resistin was linked to vascular involvement in systemic sclerosis. Visfatin was associated with regression of skin lesions in late-stage systemic sclerosis. Chemerin appears as a marker of increased risk of impaired renal function and development of skin sclerosis in the early stage of systemic sclerosis. Vaspin was indicated to have a protective role in digital ulcers development. Novel adipokines—adipsin, apelin, omentin and CTRP-3—are emerging as molecules potentially involved in SSc pathogenesis. Serum adipokine levels may be used as predictive and diagnostic factors in systemic sclerosis. However, further investigations are required to establish firm correlations between distinct adipokines and systemic sclerosis.
Literature
5.
go back to reference Akamata K, Asano Y, Taniguchi T, Yamashita T, Saigusa R, Nakamura K, Noda S, Aozasa N, Toyama T, Takahashi T, Ichimura Y, Sumida H, Tada Y, Sugaya M, Kadono T, Sato S (2015) Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis. Rheumatology 54:1308–1316. https://doi.org/10.1093/rheumatology/keu479 CrossRefPubMed Akamata K, Asano Y, Taniguchi T, Yamashita T, Saigusa R, Nakamura K, Noda S, Aozasa N, Toyama T, Takahashi T, Ichimura Y, Sumida H, Tada Y, Sugaya M, Kadono T, Sato S (2015) Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis. Rheumatology 54:1308–1316. https://​doi.​org/​10.​1093/​rheumatology/​keu479 CrossRefPubMed
10.
go back to reference Axelsson J, Bergsten A, Qureshi AR, Heimburger O, Barany P, Lonnqvist F, Lindholm B, Nordfors L, Alvestrand A, Stenvinkel P (2006) Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 69:596–604. https://doi.org/10.1038/sj.ki.5000089 CrossRefPubMed Axelsson J, Bergsten A, Qureshi AR, Heimburger O, Barany P, Lonnqvist F, Lindholm B, Nordfors L, Alvestrand A, Stenvinkel P (2006) Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 69:596–604. https://​doi.​org/​10.​1038/​sj.​ki.​5000089 CrossRefPubMed
13.
17.
go back to reference Chen B, Lyu Q, Zhang M, Zhang M, Liu W, Zhu S (2015) Leptin induces human lung fibroblast to trans-differentiate into myofibroblast. Xi bao yu fen zi mian yi xue za zhi Chin J Cell Mol Immunol 31:199–202 Chen B, Lyu Q, Zhang M, Zhang M, Liu W, Zhu S (2015) Leptin induces human lung fibroblast to trans-differentiate into myofibroblast. Xi bao yu fen zi mian yi xue za zhi Chin J Cell Mol Immunol 31:199–202
26.
34.
42.
go back to reference Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, Shikata K, Hourai S, Futami J, Watanabe E, Matsuki Y, Hiramatsu R, Akagi S, Makino H, Kanwar YS (2005) Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 102:10610–10615. https://doi.org/10.1073/pnas.0504703102 PubMedCentralCrossRefPubMed Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, Shikata K, Hourai S, Futami J, Watanabe E, Matsuki Y, Hiramatsu R, Akagi S, Makino H, Kanwar YS (2005) Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 102:10610–10615. https://​doi.​org/​10.​1073/​pnas.​0504703102 PubMedCentralCrossRefPubMed
44.
go back to reference Hofmann C, Chen N, Obermeier F, Paul G, Buchler C, Kopp A, Falk W, Schaffler A (2011) C1q/TNF-related protein-3 (CTRP-3) is secreted by visceral adipose tissue and exerts antiinflammatory and antifibrotic effects in primary human colonic fibroblasts. Inflamm Bowel Dis 17:2462–2471. https://doi.org/10.1002/ibd.21647 CrossRefPubMed Hofmann C, Chen N, Obermeier F, Paul G, Buchler C, Kopp A, Falk W, Schaffler A (2011) C1q/TNF-related protein-3 (CTRP-3) is secreted by visceral adipose tissue and exerts antiinflammatory and antifibrotic effects in primary human colonic fibroblasts. Inflamm Bowel Dis 17:2462–2471. https://​doi.​org/​10.​1002/​ibd.​21647 CrossRefPubMed
55.
go back to reference Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Braae Olesen A, Foeldvari I, Frances C, Jalili A, Just U, Kahari V, Karpati S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkotter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T (2017) European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol 31:1401–1424. https://doi.org/10.1111/jdv.14458 CrossRefPubMed Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Braae Olesen A, Foeldvari I, Frances C, Jalili A, Just U, Kahari V, Karpati S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkotter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T (2017) European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol 31:1401–1424. https://​doi.​org/​10.​1111/​jdv.​14458 CrossRefPubMed
56.
go back to reference Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Braae Olesen A, Foeldvari I, Frances C, Jalili A, Just U, Kahari V, Karpati S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkotter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T (2017) European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis. J Eur Acad Dermatol Venereol 31:1581–1594. https://doi.org/10.1111/jdv.14466 CrossRefPubMed Knobler R, Moinzadeh P, Hunzelmann N, Kreuter A, Cozzio A, Mouthon L, Cutolo M, Rongioletti F, Denton CP, Rudnicka L, Frasin LA, Smith V, Gabrielli A, Aberer E, Bagot M, Bali G, Bouaziz J, Braae Olesen A, Foeldvari I, Frances C, Jalili A, Just U, Kahari V, Karpati S, Kofoed K, Krasowska D, Olszewska M, Orteu C, Panelius J, Parodi A, Petit A, Quaglino P, Ranki A, Sanchez Schmidt JM, Seneschal J, Skrok A, Sticherling M, Sunderkotter C, Taieb A, Tanew A, Wolf P, Worm M, Wutte NJ, Krieg T (2017) European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis. J Eur Acad Dermatol Venereol 31:1581–1594. https://​doi.​org/​10.​1111/​jdv.​14466 CrossRefPubMed
58.
go back to reference Krasowska D, Rudnicka L, Dańczak-Pazdrowska A, Chodorowska G, Woźniacka A, Lis-Święty A, Czuwara J, Maj J, Majewski S, Sysa-Jędrzejowska A, Wojas-Pelc A (2017) Systemic sclerosis—diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1: diagnosis and monitoring. Dermatol Rev Przegląd Dermatologiczny 104:483–498. https://doi.org/10.5114/dr.2017.71214 CrossRef Krasowska D, Rudnicka L, Dańczak-Pazdrowska A, Chodorowska G, Woźniacka A, Lis-Święty A, Czuwara J, Maj J, Majewski S, Sysa-Jędrzejowska A, Wojas-Pelc A (2017) Systemic sclerosis—diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1: diagnosis and monitoring. Dermatol Rev Przegląd Dermatologiczny 104:483–498. https://​doi.​org/​10.​5114/​dr.​2017.​71214 CrossRef
60.
67.
go back to reference Lin S, Ma S, Lu P, Cai W, Chen Y, Sheng J (2014) Effect of CTRP3 on activation of adventitial fibroblasts induced by TGF-beta1 from rat aorta in vitro. Int J Clin Exp Pathol 7:2199–2208PubMedPubMedCentral Lin S, Ma S, Lu P, Cai W, Chen Y, Sheng J (2014) Effect of CTRP3 on activation of adventitial fibroblasts induced by TGF-beta1 from rat aorta in vitro. Int J Clin Exp Pathol 7:2199–2208PubMedPubMedCentral
79.
go back to reference Masui Y, Asano Y, Akamata K, Aozasa N, Noda S, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sumida H, Kuwano Y, Yanaba K, Tada Y, Sugaya M, Sato S, Kadono T (2014) Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis. Rheumatol Int 34:1165–1170. https://doi.org/10.1007/s00296-013-2880-3 CrossRefPubMed Masui Y, Asano Y, Akamata K, Aozasa N, Noda S, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sumida H, Kuwano Y, Yanaba K, Tada Y, Sugaya M, Sato S, Kadono T (2014) Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis. Rheumatol Int 34:1165–1170. https://​doi.​org/​10.​1007/​s00296-013-2880-3 CrossRefPubMed
80.
go back to reference Masui Y, Asano Y, Shibata S, Noda S, Akamata K, Aozasa N, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sumida H, Yanaba K, Tada Y, Sugaya M, Sato S, Kadono T (2013) A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response. Rheumatology 52:1239–1244. https://doi.org/10.1093/rheumatology/ket010 CrossRefPubMed Masui Y, Asano Y, Shibata S, Noda S, Akamata K, Aozasa N, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sumida H, Yanaba K, Tada Y, Sugaya M, Sato S, Kadono T (2013) A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response. Rheumatology 52:1239–1244. https://​doi.​org/​10.​1093/​rheumatology/​ket010 CrossRefPubMed
89.
go back to reference Olewicz-Gawlik A, Danczak-Pazdrowska A, Kuznar-Kaminska B, Batura-Gabryel H, Katulska K, Wojciech S, Trzybulska D, Hrycaj P (2015) Circulating adipokines and organ involvement in patients with systemic sclerosis. Acta Reumatol Port 40:156–162PubMed Olewicz-Gawlik A, Danczak-Pazdrowska A, Kuznar-Kaminska B, Batura-Gabryel H, Katulska K, Wojciech S, Trzybulska D, Hrycaj P (2015) Circulating adipokines and organ involvement in patients with systemic sclerosis. Acta Reumatol Port 40:156–162PubMed
92.
go back to reference Ozgen M, Koca SS, Isik B, Gundogdu B, Ustundag B, Isik A (2011) Serum adiponectin and vaspin levels in systemic sclerosis. Turk J Biochem 36:35–42 Ozgen M, Koca SS, Isik B, Gundogdu B, Ustundag B, Isik A (2011) Serum adiponectin and vaspin levels in systemic sclerosis. Turk J Biochem 36:35–42
113.
go back to reference Timár O, Soltész P, Szamosi S, Dér H, Szántó S, Szekanecz Z, Szücs G (2008) Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheumatol 35:1329–1333PubMed Timár O, Soltész P, Szamosi S, Dér H, Szántó S, Szekanecz Z, Szücs G (2008) Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheumatol 35:1329–1333PubMed
114.
go back to reference Truchetet ME, Brembilla NC, Montanari E, Lonati P, Raschi E, Zeni S, Fontao L, Meroni PL, Chizzolini C (2013) Interleukin-17A + cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement. Arthritis Rheum 65:1347–1356. https://doi.org/10.1002/art.37860 CrossRefPubMed Truchetet ME, Brembilla NC, Montanari E, Lonati P, Raschi E, Zeni S, Fontao L, Meroni PL, Chizzolini C (2013) Interleukin-17A + cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement. Arthritis Rheum 65:1347–1356. https://​doi.​org/​10.​1002/​art.​37860 CrossRefPubMed
118.
go back to reference Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T (2003) Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278:40352–40363. https://doi.org/10.1074/jbc.M300365200 CrossRefPubMed Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T (2003) Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278:40352–40363. https://​doi.​org/​10.​1074/​jbc.​M300365200 CrossRefPubMed
126.
go back to reference Xue K, Liu H, Jian Q, Liu B, Zhu D, Zhang M, Gao L, Li C (2013) Leptin induces secretion of pro-inflammatory cytokines by human keratinocytes in vitro–a possible reason for increased severity of psoriasis in patients with a high body mass index. Exp Dermatol 22:406–410. https://doi.org/10.1111/exd.12162 CrossRefPubMed Xue K, Liu H, Jian Q, Liu B, Zhu D, Zhang M, Gao L, Li C (2013) Leptin induces secretion of pro-inflammatory cytokines by human keratinocytes in vitro–a possible reason for increased severity of psoriasis in patients with a high body mass index. Exp Dermatol 22:406–410. https://​doi.​org/​10.​1111/​exd.​12162 CrossRefPubMed
132.
133.
go back to reference Zhang K, Guo Y, Ge Z, Zhang Z, Da Y, Li W, Zhang Z, Xue Z, Li Y, Ren Y, Jia L, Chan KH, Yang F, Yan J, Yao Z, Xu A, Zhang R (2017) Adiponectin suppresses T helper 17 cell differentiation and limits autoimmune CNS inflammation via the SIRT1/PPARgamma/RORgammat pathway. Mol Neurobiol 54:4908–4920. https://doi.org/10.1007/s12035-016-0036-7 CrossRefPubMed Zhang K, Guo Y, Ge Z, Zhang Z, Da Y, Li W, Zhang Z, Xue Z, Li Y, Ren Y, Jia L, Chan KH, Yang F, Yan J, Yao Z, Xu A, Zhang R (2017) Adiponectin suppresses T helper 17 cell differentiation and limits autoimmune CNS inflammation via the SIRT1/PPARgamma/RORgammat pathway. Mol Neurobiol 54:4908–4920. https://​doi.​org/​10.​1007/​s12035-016-0036-7 CrossRefPubMed
Metadata
Title
The role of adipokines in systemic sclerosis: a missing link?
Authors
Jakub Żółkiewicz
Anna Stochmal
Lidia Rudnicka
Publication date
01-05-2019
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 4/2019
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-019-01893-1

Other articles of this Issue 4/2019

Archives of Dermatological Research 4/2019 Go to the issue